Brief: Ibex Obtains CE-IVD Mark For Ai-Powered Cancer Detection
Feb 27 (Reuters) - IBEX Technologies Inc IBT.V :
* IBEX OBTAINS CE-IVD MARK FOR AI-POWERED CANCER DETECTION
* IBEX TECHNOLOGIES - GALEN PROSTATE SOLUTION DEMONSTRATES
OUTSTANDING RESULTS IN A BLINDED STUDY
Source text for Eikon: ID:nPn3fyxKJa
Further company coverage: IBT.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IBEX Technologies
See all newsBrief: Ibex Technologies Signs Agreement For Sale Of The Company
Brief: IBEX Technologies Announces Renewal Of Normal Course Issuer Bid
Brief: IBEX Reports Results For The Third Quarter And The Nine Months Ended April 30, 2023
Brief: Ibex Technologies Announces Normal Course Issuer Bid
Brief: Ibex Technologies Q3 Revenue Rose 51 Percent To C$2.209 Million